Leidos Holdings, Inc.
—- Market cap
- $16.26B
- Debt
- —
- Cash
- −$1.11B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: LDOS stock price at discount vs DHR $129.55 current versus $442.36 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DHR's multiple
Implied fair value · at LDOS's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 88% equity / 12% debt
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Leidos Holdings, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
DANAHER CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTERNATIONAL BUSINESS MACHINES CORP
LDOS vs IBM
Accenture plc
LDOS vs ACN
LOCKHEED MARTIN CORP
LDOS vs LMT
NORTHROP GRUMMAN CORP /DE/
LDOS vs NOC
GENERAL DYNAMICS CORP
LDOS vs GD
ZEBRA TECHNOLOGIES CORP
LDOS vs ZBRA
AGILENT TECHNOLOGIES, INC.
LDOS vs A
ILLUMINA, INC.
LDOS vs ILMN
JOHNSON & JOHNSON
LDOS vs JNJ
ABBOTT LABORATORIES
LDOS vs ABT
LOEWS CORP
LDOS vs L
BERKSHIRE HATHAWAY INC
LDOS vs BRK-B
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LDOS can sustain its 24.9% ROIC while improving margins without meaningfully increasing leverage, then LDOS may deserve a higher multiple; otherwise, the current discount versus DHR likely reflects structural profitability differences rather than a clear mispricing.
LDOS trades at a large valuation discount to DHR across P/E, P/S, EV/EBITDA, and EV/Revenue, but the gap is not surprising given DHR's materially superior profitability. The stated implied price of $394.89 versus the current price of $104.92 suggests 276.4% upside on a P/E basis, but that comparison likely overstates fair value because DHR’s multiple is far richer than LDOS’s operating profile.
Supporting Metrics